Ezetimibe and fenofibrate combination therapy for mixed hyperlipidemia.

Abstract

The ezetimibe and fenofibrate combination regimen was recently approved by the U.S. Food and Drug Administration for treatment of mixed hyperlipidemia. This powerful lipid-modifying therapy takes advantage of the different mechanisms of action of the two individual components. Ezetimibe selectively inhibits intestinal uptake of dietary and biliary… (More)

Topics

Cite this paper

@article{Moon2007EzetimibeAF, title={Ezetimibe and fenofibrate combination therapy for mixed hyperlipidemia.}, author={Yong S K Moon and Patricia Chun and Suna Chung}, journal={Drugs of today}, year={2007}, volume={43 1}, pages={35-45} }